Significance: Oxidation and reduction events are critical to physiological and pathological processes and are highly regulated. Herein, we present evidence for the role of Ras and Rho GTPases in controlling these events and the unique underlying mechanisms. Evidence for redox regulation of Ras GTPases that contain a redox-sensitive cysteine (X) in the conserved NKXD motif is presented, and a growing consensus supports regulation by a thiyl radical-mediated oxidation mechanism. We also discuss the debate within the literature regarding whether 2e− oxidation mechanisms also regulate Ras GTPase activity. Recent Advances: We examine the increasing in vitro and cell-based data supporting oxidant-mediated activation of Rho GTPases that contain a redox-sensitive cysteine at the end of the conserved phosphoryl-binding loop (p-loop) motif (GXXXXG[S/T]C). While this motif is distinct from Ras, these data suggest a similar 1e− oxidation-mediated activation mechanism. Critical Issues: We also review the data showing that the unique p-loop placement of the redox-sensitive cysteine in Rho GTPases supports activation by 2e− cysteine oxidation. Finally, we examine the role that Ras and Rho GTPases play in controlling key oxidant-regulating enzymes in the cell, and we speculate on a feedback mechanism. Future Directions: Given that these GTPases and redox-regulating enzymes are involved in multiple physiological and pathological processes, we discuss future experiments that may clarify the interplay between them. Antioxid. Redox Signal. 18, 250–258.
Get full access to this article
View all access options for this article.
References
1.
AdachiT, PimentelDR, HeibeckT, HouX, LeeYJ, JiangB, IdoY, CohenRA. S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem, 279:29857–29862. 2004.
2.
AghajanianA, WittchenES, CampbellSL, BurridgeK. Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif. PloS one, 4:e8045. 2009.
3.
AminJK, XiaoL, PimentalDR, PaganoPJ, SinghK, SawyerDB, ColucciWS. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J Mol Cell Cardiol, 33:131–139. 2001.
4.
AugustoO, BoniniMG, AmansoAM, LinaresE, SantosCC, De MenezesSL. Nitrogen dioxide and carbonate radical anion: two emerging radicals in biology. Free Radic Biol Med, 32:841–859. 2002.
5.
BeckmanJS, KoppenolWH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol, 271:C1424–C1437. 1996.
6.
BedardK, KrauseKH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev, 87:245–313. 2007.
7.
BokochGM, DieboldBA. Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood, 100:2692–2696. 2002.
8.
ClavreulN, AdachiT, PimentalDR, IdoY, SchoneichC, CohenRA. S-glutathiolation by peroxynitrite of p21ras at cysteine-118 mediates its direct activation and downstream signaling in endothelial cells. FASEB J, 20:518–520. 2006.
9.
ClavreulN, BachschmidMM, HouX, ShiC, IdrizovicA, IdoY, PimentelD, CohenRA. S-glutathiolation of p21ras by peroxynitrite mediates endothelial insulin resistance caused by oxidized low-density lipoprotein. Arterioscler Thromb Vasc Biol, 26:2454–2461. 2006.
10.
DavisMF, VigilD, CampbellSL. Regulation of Ras proteins by reactive nitrogen species. Free Radic Biol Med, 51:565–575. 2011.
11.
DeLeoFR, QuinnMT. Assembly of the phagocyte NADPH oxidase: molecular interaction of oxidase proteins. J Leukoc Biol, 60:677–691. 1996.
12.
Di-PoiN, FaureJ, GrizotS, MolnarG, PickE, DagherMC. Mechanism of NADPH oxidase activation by the Rac/Rho-GDI complex. Biochemistry, 40:10014–10022. 2001.
13.
DudzinskiDM, IgarashiJ, GreifD, MichelT. The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol, 46:235–276. 2006.
14.
ForstermannU, SessaWC. Nitric oxide synthases: regulation and function. Eur Heart J, 2011[Epub ahead of print]DOI:10.1093/eurheartj/ehr304.
15.
GerhardR, JohnH, AktoriesK, JustI. Thiol-modifying phenylarsine oxide inhibits guanine nucleotide binding of Rho but not of Rac GTPases. Mol Pharmacol, 63:1349–1355. 2003.
16.
HarrazMM, MardenJJ, ZhouW, ZhangY, WilliamsA, SharovVS, NelsonK, LuoM, PaulsonH, SchoneichC, EngelhardtJF. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest, 118:659–670. 2008.
17.
HeoJ. Redox control of GTPases: from molecular mechanisms to functional significance in health and disease. Antioxid Redox Signal, 14:689–724. 2011.
18.
HeoJ, CampbellSL. Mechanism of p21Ras S-nitrosylation and kinetics of nitric oxide-mediated guanine nucleotide exchange. Biochemistry, 43:2314–2322. 2004.
19.
HeoJ, CampbellSL. Mechanism of redox-mediated guanine nucleotide exchange on redox-active Rho GTPases. J Biol Chem, 280:31003–31010. 2005.
20.
HeoJ, CampbellSL. Ras regulation by reactive oxygen and nitrogen species. Biochemistry, 45:2200–2210. 2006.
HordijkPL. Regulation of NADPH oxidases: the role of Rac proteins. Circ Res, 98:453–462. 2006.
24.
IbizaS, Perez-RodriguezA, OrtegaA, Martinez-RuizA, BarreiroO, Garcia-DominguezCA, VictorVM, EspluguesJV, RojasJM, Sanchez-MadridF, SerradorJM. Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells. Proc Natl Acad Sci U S A, 105:10507–10512. 2008.
25.
JaffeAB, HallA. Rho GTPases: biochemistry and biology. Ann Rev Cell Dev Biol, 21:247–269. 2005.
KarnoubAE, DerCJ, CampbellSL. The insert region of Rac1 is essential for membrane ruffling but not cellular transformation. Mol Cell Biol, 21:2847–2857. 2001.
28.
KissnerR, KoppenolWH. Product distribution of peroxynitrite decay as a function of pH, temperature, and concentration. J Am Chem Soc, 124:234–239. 2002.
29.
KjeldgaardM, NyborgJ, ClarkBF. The GTP binding motif: variations on a theme. FASEB J, 10:1347–1368. 1996.
30.
KouR, MichelT. Epinephrine regulation of the endothelial nitric-oxide synthase: roles of RAC1 and beta3-adrenergic receptors in endothelial NO signaling. J Biol Chem, 282:32719–32729. 2007.
31.
KuncewiczT, BalakrishnanP, SnuggsMB, KoneBC. Specific association of nitric oxide synthase-2 with Rac isoforms in activated murine macrophages. Am J Physiol Renal Physiol, 281:F326–F336. 2001.
32.
LancasterJRJr., XieK. Tumors face NO problems?Cancer Res, 66:6459–6462. 2006.
LanderHM, OgisteJS, TengKK, NovogrodskyA. p21ras as a common signaling target of reactive free radicals and cellular redox stress. J Biol Chem, 270:21195–21198. 1995.
35.
LimKH, AncrileBB, KashatusDF, CounterCM. Tumour maintenance is mediated by eNOS. Nature, 452:646–649. 2008.
36.
LiochevSI, FridovichI. The effects of superoxide dismutase on H2O2 formation. Free Radic Biol Med, 42:1465–1469. 2007.
37.
LoirandG, PacaudP. The role of Rho protein signaling in hypertension. Nat Rev Cardiol, 7:637–647. 2010.
38.
LundbergJO, WeitzbergE. Nitrite reduction to nitric oxide in the vasculature. Am J Physiol Heart Circ Physiol, 295:H477–H478. 2008.
39.
MerenyiG, LindJ, GoldsteinS, CzapskiG. Peroxynitrous acid homolyzes into *OH and *NO2 radicals. Chem Res Toxicol, 11:712–713. 1998.
40.
MiyanoK, KogaH, MinakamiR, SumimotoH. The insert region of the Rac GTPases is dispensable for activation of superoxide-producing NADPH oxidases. Biochem J, 422:373–382. 2009.
41.
MottHR, CarpenterJW, CampbellSL. Structural and functional analysis of a mutant Ras protein that is insensitive to nitric oxide activation. Biochemistry, 36:3640–3644. 1997.
42.
NimnualAS, TaylorLJ, Bar-SagiD. Redox-dependent downregulation of Rho by Rac. Nat Cell Biol, 5:236–241. 2003.
43.
PoliG, LeonarduzziG, BiasiF, ChiarpottoE. Oxidative stress and cell signalling. Curr Med Chem, 11:1163–1182. 2004.
SawadaN, SalomoneS, KimHH, KwiatkowskiDJ, LiaoJK. Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1. Circ Res, 103:360–368. 2008.
48.
SelvakumarB, HessDT, Goldschmidt-ClermontPJ, StamlerJS. Co-regulation of constitutive nitric oxide synthases and NADPH oxidase by the small GTPase Rac. FEBS Letters, 582:2195–2202. 2008.
49.
SzaboC, IschiropoulosH, RadiR. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov, 6:662–680. 2007.
50.
TrautTW. Physiological concentrations of purines and pyrimidines. Mol Cell Biochem, 140:1–22. 1994.
51.
TsujitaM, BatistaWL, OgataFT, SternA, MonteiroHP, AraiRJ. The nitric oxide-sensitive p21Ras-ERK pathway mediates S-nitrosoglutathione-induced apoptosis. Biochem Biophys Res Commun, 369:1001–1006. 2008.
52.
TsutsuiM, ShimokawaH, OtsujiY, YanagiharaN. Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases. Pharmacol Ther, 128:499–508. 2010.
53.
UllrichV, KissnerR. Redox signaling: bioinorganic chemistry at its best. J Inorg Biochem, 100:2079–2086. 2006.
54.
ValkoM, IzakovicM, MazurM, RhodesCJ, TelserJ. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem, 266:37–56. 2004.
55.
WardmanP, CandeiasLP. Fenton chemistry: an introduction. Radiat Res, 145:523–531. 1996.
56.
WilliamsJG, PappuK, CampbellSL. Structural and biochemical studies of p21Ras S-nitrosylation and nitric oxide-mediated guanine nucleotide exchange. Proc Natl Acad Sci U S A, 100:6376–6381. 2003.
57.
ZuckerbraunBS, StoyanovskyDA, SenguptaR, ShapiroRA, OzanichBA, RaoJ, BarbatoJE, TzengE. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA. Am J Physiol Cell Physiol, 292:C824–C831. 2007.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
